FDA Vet-LIRN Capacity-Building of Ohio ADDL to support rapid testing for COVID-19
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: 1U18FD008023-01
Grant search
Key facts
Disease
COVID-19Start & end year
20232024Known Financial Commitments (USD)
$40,000Funder
National Institutes of Health (NIH)Principal Investigator
Melanie PraratResearch Location
United States of AmericaLead Research Institution
OHIO STATE DEPARTMENT OF AGRICULTUREResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
This proposal from the Ohio Department of Agriculture (ODA) is in response to Funding Opportunity Announcement (FOA) PAR-18-604 from the Food and Drug Administration (FDA) Center for Veterinary Medicine (CVM) Veterinary Laboratory Investigation and Response Network (Vet-LIRN). This proposal from ODA's Animal Disease Diagnostic Laboratory (ADDL) addresses the following key project area: 1. Purchase of equipment to build testing capacity of SARS-CoV-2. a. We are requesting funds to support the purchase of a real-time PCR platform budge for SARS-CoV-2 testing of diagnostic samples submitted to the Ohio ADDL. Additionally, participation in additional projects such as method development and/or method validation/improvement and matrix extension work as determined by the VPO may be included in the capacity-building funds. This proposal will increase the capacity of our laboratory to conduct SARS-CoV-2 diagnostic testing for high-throughput sample processing capability and data analysis by maintaining redundancy in testing equipment to reduce any delays in testing due to equipment malfunctions or needed repairs.